Lidocaine and epinephrine mixture relieves pain from impacted molar surgery

ISRCTN ISRCTN13866362
DOI https://doi.org/10.1186/ISRCTN13866362
Secondary identifying numbers 42/2016
Submission date
27/09/2024
Registration date
01/10/2024
Last edited
17/01/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Mandibular third molars (the teeth at the back of the lower jaw) typically erupt in humans between 18 and 24 years of age. Accordingly, the lower third molar will commonly become impacted (stuck in the gum) and will have to be removed. However, discomfort and adverse effects may occur following an impacted tooth extraction such as edema (swelling), numbness, and excessive bleeding. Pain is the most prevalent problem following impacted tooth extractions. Pain perception affects individuals differently. The pain experienced from dental extraction and dental anesthesia can produce different responses among patients.
Local anesthetic drugs such as lidocaine and mepivacaine are used to alleviate pain during surgery or dental work. However, certain side effects, including redness, swelling, itching, dizziness, drowsiness, nausea, and, rarely, severe allergic reactions, have been observed with lidocaine . Bupivacaine reduced pain after impacted tooth extraction but did not decrease analgesic drug intake. Furthermore, irrigation of the tooth socket with bupivacaine after removal of the impacted third molar could significantly reduce the discomfort of the patient when compared to normal saline (salt water) irrigation.
The aim of this study is to compare the analgesic effects of lidocaine and bupivacaine compared with normal saline solution irrigation in patients after surgical removal of mandibular third molars.

Who can participate?
Patients aged between 18 and 25 years with impacted third molars

What does the study involve?
Participants are randomly allocated to receive lidocaine or bupivacaine post-operatively. Either molar side was randomly selected for the initial surgery and flushed with anesthetics before suture removal. Patients were then evaluated for pain levels and asked to respond to questionnaires at 2, 4, 6, and 8 hours. Another tooth was surgically extracted after 4 weeks and patients were monitored as they had been for the previous surgery.

What are the possible benefits and risks of participating?
Irrigation of lidocaine plus epinephrine could help reduce pain after wisdom tooth extraction/surgery in the early stages, even though the effect of the injected anesthesia is somewhat reduced. In addition, the irrigation will allow the patients not to bite on gauze, which may be inconvenient to take painkillers such as paracetamol or/and ibuprofen. Moreover, this technique is very helpful for postoperative patients, especially in cases where there may be severe pain after surgery due to a difficult time-consuming operation with a high pain response.
There may be a risk of a dry socket but the percentage is very low, and some patients may be allergic or hypersensitive to the epinephrine.

Where is the study run from?
Chiang Mai University (Thailand)

When is the study starting and how long is it expected to run for?
October 2014 to December 2019

Who is funding the study?
Chiang Mai University (Thailand)

Who is the main contact?
Assistant Professor Dr. Vuttinun Chatupos, vuttinunch@yahoo.co.th

Contact information

Prof Somdet Srichairatanakool
Public, Scientific, Principal Investigator

Department of Biochemistry
Faculty of Medicine
Chiang Mai University
Chiangmai
50200
Thailand

ORCiD logoORCID ID 0000-0002-5706-8781
Phone +66 (0)810353463
Email somdet.s@cmu.ac.th

Study information

Study designRandomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Dental clinic
Study typeTreatment
Participant information sheet 46142_PIS_V2.pdf
Scientific titleEvaluation of the effectiveness of lidocaine with epinephrine irrigation in reducing acute pain from surgical removal of mesioangular-impacted third molars
Study objectivesLidocaine would exert not only systemic anaesthetic but also local anti-pain properties to be used in postoperative patients with mesioangular impacted molars.
Ethics approval(s)

1. Approved 03/12/2014, Chiang Mai University (Faculty of Dentistry, Chiangmai, 50200, Thailand; +66 (0)53944445; anak.ia@cmu.ac.th), ref: 52/2014

2. Approved 24/08/2016, Chiang Mai University (Faculty of Dentistry, Chiangmai, 50200, Thailand; +66 (0)53944445; anak.ia@cmu.ac.th), ref: 52/2014

Health condition(s) or problem(s) studiedImpacted lower mandibular molars
InterventionParticipants were randomly divided by block randomization to receive 2% lidocaine or 0.5% bupivacaine post-operatively. Either molar side was randomly selected for the initial surgery and flushed with anesthetics before suture removal. Patients were then evaluated for pain levels using the Visual Analog Scale (VAS) tool and asked to respond to questionnaires at 2, 4, 6, and 8 hours. Another tooth was surgically extracted after 4 weeks and patients were again monitored, as they had been for the previous surgery.
Intervention typeDrug
Pharmaceutical study type(s)Not Applicable
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Lidocaine, epinephrine
Primary outcome measure1. Duration of surgery and postoperative irrigation volume of NSS or lidocaine plus epinephrine used, recorded after surgery
2. Pain is measured using the visual analogue score (VAS) at baseline, 24, 48 and 72 hours
3. Number of paracetamol consumed, recorded after surgery
4. VAS-aided assessment of pain measured in participants receiving bupivacaine or lidocaine at 2, 4, 6, and 8 hours post-operation
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date01/10/2014
Completion date31/12/2019

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit25 Years
SexBoth
Target number of participants34
Total final enrolment34
Key inclusion criteria1. Aged between 18 and 25 years
2. Systemically deemed to be healthy
3. Orthodontically indicated for impacted lower third molar on both sides as depicted in panoramic radiographs
4. Non-allergic to amoxicillin and paracetamol
5. Had not previously experienced inflammation or infection of the teeth and gums around the lower molars before treatment
Key exclusion criteria1. History of neurological disorders
2. Allergies to lidocaine and bupivacaine
3. Received steroid medication
Date of first enrolment01/10/2015
Date of final enrolment30/09/2016

Locations

Countries of recruitment

  • Thailand

Study participating centre

Chiang Mai University
Out-Patient Department Number 4
Department of Oral and Maxillofacial Surgery
Faculty of Dentistry
Chiang Mai
50200
Thailand

Sponsor information

Chiang Mai University
University/education

Department of Biochemistry
Faculty of Medicine
Chiangmai
50200
Thailand

Phone +66 (0)53944429
Email cmdj.dent@cmu.ac.th
Website http://www.dent.cmu.ac.th/mdj/frontend/web/?r=site/viewdata&id=7
ROR logo "ROR" https://ror.org/05m2fqn25

Funders

Funder type

Government

National Research Council of Thailand
Government organisation / National government
Alternative name(s)
NRCT
Location
Thailand
Chiang Mai University
Government organisation / Universities (academic only)
Alternative name(s)
Chiang Mai University, THAILAND, มหาวิทยาลัยเชียงใ, มหาวิทยาลัยเชียงใหม่, 清迈大学, CMU
Location
Thailand

Results and Publications

Intention to publish date15/10/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publications in peer-reviewed journals
IPD sharing planThe dataset generated during and/or the current study will be available upon request from Professor Dr Somdet Srichairatanakool, PhD, somdet.s@cmu.ac.th

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet version 2 01/10/2024 No Yes
Protocol file version 2 01/10/2024 No No
Results article 17/12/2024 17/01/2025 Yes No

Additional files

46142_PROTOCOL_V2.pdf
46142_PIS_V2.pdf

Editorial Notes

17/01/2025: Publication reference added.
02/10/2024: Internal review.
30/09/2024: Study's existence confirmed by Chiang Mai University.